{"cursor":"8499","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| verifiedrevid = 462252392 IUPAC_name = (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-\n| triol image = Miglustat 2.svg width = 185\n\n\n| tradename = Drugs.com = MedlinePlus = a604015 licence_US = Miglustat\n| pregnancy_AU =  pregnancy_US = X\n| pregnancy_category = legal_AU =  legal_CA = \n| legal_UK =  legal_US = Rx-only\n| legal_status = routes_of_administration = Oral\n\n\n| bioavailability = 97% protein_bound = Nil metabolism = Nil elimination_half-\n| life = 6â7 hours excretion = Renal, unchanged\n\n\n| CAS_number_Ref = CAS_number = 72599-27-0 ATC_prefix = A16 ATC_suffix = AX06\n| PubChem = 51634 DrugBank_Ref = DrugBank = DB00419 ChemSpiderID_Ref =\n| ChemSpiderID = 46764 UNII_Ref = UNII = ADN3S497AZ ChEBI_Ref = ChEBI = 50381\n| ChEMBL_Ref = ChEMBL = 1029\n\n\n| C=10 | H=21 | N=1 | O=4 molecular_weight = 219.28 g/mol smiles =\n| OC[C@H]1N(CCCC)C[C@H](O)[C@@H](O)[C@@H]1O InChI = 1/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-\n| 6H2,1H3/t7-,8+,9-,10-/m1/s1 InChIKey = UQRORFVVSGFNRO-UTINFBMNBD StdInChI_Ref\n| = StdInChI = 1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-\n| 6H2,1H3/t7-,8+,9-,10-/m1/s1 StdInChIKey_Ref = StdInChIKey = UQRORFVVSGFNRO-UTINFBMNSA-\n| N synonyms = 1,5-(butylimino)-1,5-dideoxy-D-glucitol, N-butyl-deoxynojirimycin\n}} 'Miglustat' is a drug developed by Actelion and is used primarily to treat\nType 1 Gaucher disease (GD1). It is marketed under the trade name 'Zavesca'.\nMiglustat (OGT 918, N-butyl-deoxynojirimycin) is an imino sugar (molecular\nweight: 219 daltons), a synthetic analogue of D-glucose  and a white to off-white crystalline solid that has a\nbitter taste The primary pharmacological activity of miglustat is inhibition of\nthe enzyme glucosylceramide synthase, catalyzing the first step in the\nbiosynthesis of glycosphingolipids (GSL), i.e., the formation of\nglucosylceramide (GlcCer). Reduced formation of GlcCer will lead to decreased\nbiosynthesis of more complex GSL. This therapeutic principle, called substrate\nreduction therapy (SRT), may be useful in disorders of intracellular\n(predominantly lysosomal) accumulation of GSL either due to their deficient\nbreakdown or intracellular transport/trafficking. http://www.fda.gov/downlo-\nads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabo-\nlicDrugsAdvisoryCommittee/UCM196758.pdf Miglustat exhibits a large volume\nof distribution and has the capacity to access deep organs such as the brain,\nbone and lung.\n\nMiglustat inhibits glucosylceramide synthase, an\nessential enzyme for the synthesis of most glycosphingolipids (it forms\nglucosylceramide and accumulates within the macrophages). Miglustat is used to\ntreat adults with mild to moderate type 1 Gaucher disease and it is the first\ntreatment to be approved for patients with Niemann-Pick type C disease.\nMiglustat may only be used in the treatment of type 1 Gaucher patients for whom\nenzyme replacement therapy is unsuitable Journal of Inherit Metabol.\nDiseases, 2003;26:513-526. Cox T et cols. THE ROLE OF THE IMINOSUGAR N-\nBUTYLDEOXINOJIRIMYCIN (MIGLUSTAT) IN THE MANAGEMENT OF TYPE I (NONNEURONOPATHIC)\nGAUCHER DISEASE: A POSITION STATEMENT. and it's been approved in the\nEuropean Union for the treatment of progressive neurological manifestations in\nadult or pediatric patients with Niemann-Pick type C disease (NPC). It has also\nbeen approved for NPC treatment in Canada, Switzerland, Brazil, Australia,\nTurkey and Israel but not in the United States.\n\nType 1 Gaucher disease is an autosomal recessive disorder one gets from both\nparents. People with type 1 Gaucher have a defect in the enzyme called\nglucocerebrosidase (also known as acid Î²-glucosidase) that acts on a fatty\nsubstance glucosylceramide (also known as glucocerebroside). Accumulation of\nglucosylceramide causes liver and spleen enlargement, changes in the bone marrow\nand blood, and bone disease. Treatment with miglustat is known as substrate\nreduction therapy (SRT). Unlike enzyme replacement therapy (ERT), which has a\ndirect effect on the breakdown of glycosphingolipids, the concept of SRT in\nGaucher disease involves reduction of the delivery of potential storage material\nto the macrophage system. Patients treated with miglustat for 3 years show\nsignicant improvements in organ volumes and haematological parameters. Miglustat\nwas effective over time and showed acceptable tolerability in patients who\ncontinued with treatment for 3 years. Journal of Inherit Metabol. Diseases,\n2004;27:757-766. Elstein et cols. SUSTAINED THERAPEUTIC EFFECTS OF ORAL\nMIGLUSTAT IN TYPE I GAUCHER DISEASE. It is also being investigated to\ntreat Tay-sachs disease, particularly late-onset Tay-Sachs. http://www.clinicaltrials.gov/ct2/show/NCT00672022?term=tay-\nsachs&rank=3 In October 2007, Actelion initiated a Phase IIa\nproof-of-concept clinical trial with Miglustat in cystic fibrosis (CF). It is\nthe first time that Miglustat is being tested in a clinical setting involving 25\nCF patients affected by the specific delF508 mutation.\n","linknr":265,"url":"miglustat","recorded":1376426882,"links":["/w/index.php?title=Miglustat&action=edit","/w/index.php?title=Miglustat&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Miglustat","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/File:Miglustat_2.svg","//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Miglustat_2.svg/185px-Miglustat_2.svg.png","/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/miglustat.html","/wiki/MedlinePlus","http://www.nlm.nih.gov/medlineplus/druginfo/meds/a604015.html","/wiki/Regulation_of_therapeutic_goods","/wiki/U.S._Food_and_Drug_Administration","http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Miglustat&SearchType=BasicSearch","/wiki/Pregnancy_category","/wiki/United_States","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Bioavailability","/wiki/Plasma_protein_binding","/wiki/Drug_metabolism","/wiki/Biological_half-life","/wiki/Excretion","/wiki/Kidney","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=72599-27-0&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_A16","http://www.whocc.no/atc_ddd_index/?code=A16AX06","/wiki/PubChem","http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=51634","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00419","/wiki/ChemSpider","http://www.chemspider.com/Chemical-Structure.46764","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ADN3S497AZ","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEBI","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50381","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1029","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Synonym","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Molecular_mass","/wiki/Simplified_molecular_input_line_entry_specification","/wiki/International_Chemical_Identifier","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462252392&page2=Miglustat","/wiki/Actelion","/wiki/Gaucher_disease","#cite_note-pmid21988669-1","#cite_note-2","/wiki/Glucosylceramide_synthase","#cite_note-pmid17720777-3","/wiki/Enzyme","/wiki/Glycosphingolipid","#cite_note-4","/wiki/Autosomal_recessive","/wiki/Glucocerebrosidase","/w/index.php?title=Acid_%CE%B2-glucosidase&action=edit&redlink=1","/wiki/Glucosylceramide","/wiki/Glucocerebroside","/wiki/Substrate_reduction_therapy","#cite_note-5","/wiki/Tay-sachs_disease","#cite_note-6","#cite_note-7","/wiki/Cystic_fibrosis","/w/index.php?title=Miglustat&action=edit&section=1","/w/index.php?title=Miglustat&veaction=edit&section=1","#cite_note-8","#cite_note-9","/wiki/Amine_alkylation","/wiki/File:Miglustat_synthesis.svg","//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Miglustat_synthesis.svg/1000px-Miglustat_synthesis.svg.png","/w/index.php?title=Miglustat&action=edit&section=2","/w/index.php?title=Miglustat&veaction=edit&section=2","/wiki/Miglitol","/wiki/Isofagomine_tartrate","/w/index.php?title=Miglustat&action=edit&section=3","/w/index.php?title=Miglustat&veaction=edit&section=3","#cite_ref-pmid21988669_1-0","http://dx.doi.org/10.1021/mp200313e","/wiki/Molecular_Pharmaceutics","/wiki/Digital_object_identifier","http://dx.doi.org/10.1021%2Fmp200313e","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21988669","#cite_ref-2","http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196758.pdf","#cite_ref-pmid17720777_3-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1177%2F0091270007305298","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17720777","#cite_ref-4","#cite_ref-5","#cite_ref-6","http://www.clinicaltrials.gov/ct2/show/NCT00672022?term=tay-sachs&rank=3","#cite_ref-7","/wiki/Digital_object_identifier","http://dx.doi.org/10.1111%2Fj.1471-4159.2004.02650_.x","/wiki/International_Standard_Serial_Number","//www.worldcat.org/issn/0022-3042","/wiki/Help:CS1_errors#displayauthors","#cite_ref-8","http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000435/WC500046721.pdf","#cite_ref-9","http://onlinelibrary.wiley.com/doi/10.1002/9780470742761.ch8/pdf","/wiki/Template:Other_alimentary_tract_and_metabolism_products","/wiki/Template_talk:Other_alimentary_tract_and_metabolism_products","//en.wikipedia.org/w/index.php?title=Template:Other_alimentary_tract_and_metabolism_products&action=edit","/wiki/Alimentary_tract","/wiki/Metabolism","/wiki/ATC_code_A16","/wiki/Amino_acid","/wiki/Levocarnitine","/wiki/S-Adenosyl_methionine","/wiki/Levoglutamide","/wiki/Cysteamine","/wiki/Carglumic_acid","/wiki/Betaine","/wiki/Enzyme","/wiki/Carbohydrate_metabolism","/wiki/Sucrase","/wiki/Sacrosidase","/wiki/Alpha-glucosidase","/wiki/Alglucosidase_alfa","/wiki/Glycolipid","/wiki/Sphingolipid","/wiki/Glucocerebrosidase","/wiki/Alglucerase","/wiki/Imiglucerase","/wiki/Taliglucerase_alfa","/wiki/Velaglucerase_alfa","/wiki/Alpha-galactosidase","/wiki/Agalsidase_alfa","/wiki/Agalsidase_beta","/wiki/Glycosaminoglycan","/wiki/Iduronidase","/wiki/Laronidase","/wiki/Arylsulfatase_B","/wiki/Galsulfase","/wiki/Iduronate-2-sulfatase","/wiki/Idursulfase","/wiki/Anethole_trithione","/wiki/Glycerol_phenylbutyrate","/wiki/Nitisinone","/wiki/Tetrahydrobiopterin","/wiki/Sodium_phenylbutyrate","/wiki/Teduglutide","/wiki/Tioctic_acid","/wiki/Zinc_acetate","/wiki/Template:Medicine_navs","/wiki/Digestion","/wiki/Template:Digestive_tract","/wiki/Template:Accessory_digestive_glands","/wiki/Template:Abdominopelvic_cavity","/wiki/Template:Gastrointestinal_physiology","/wiki/Template:Development_of_digestive_system","/wiki/Template:Digestive_enzymes","/wiki/Template:Digestive_system_diseases","/wiki/Template:Congenital_malformations_and_deformations_of_digestive_system","/wiki/Template:Digestive_system_neoplasia","/wiki/Template:Digestive_system_and_abdomen_symptoms_and_signs","/wiki/Template:Eponymous_medical_signs_for_digestive_system_and_general_abdominal_signs","/wiki/Template:Digestive_system_procedures","/wiki/ATC_code_A","/wiki/Template:Antacids","/wiki/Template:Drugs_for_peptic_ulcer_and_GORD","/wiki/Template:Drugs_for_functional_gastrointestinal_disorders","/wiki/Template:Antiemetics","/wiki/Template:Bile_and_liver_therapy","/wiki/Template:Laxatives","/wiki/Template:Antidiarrheals,_intestinal_anti-inflammatory/anti-infective_agents","/wiki/Template:Anabolic_steroids","/wiki/Template:Other_alimentary_tract_and_metabolism_products","/wiki/Template:Clinical_biochemistry_blood_tests","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Miglustat&oldid=544881193","/wiki/Help:Category","/wiki/Category:Transferase_inhibitors","/wiki/Category:Orphan_drugs","/wiki/Category:Piperidines","/wiki/Category:Pages_using_citations_with_old-style_implicit_et_al.","/w/index.php?title=Special:UserLogin&returnto=Miglustat&type=signup","/w/index.php?title=Special:UserLogin&returnto=Miglustat","/wiki/Miglustat","/wiki/Talk:Miglustat","#","/wiki/Miglustat","/w/index.php?title=Miglustat&action=edit","/w/index.php?title=Miglustat&veaction=edit","/w/index.php?title=Miglustat&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Miglustat","/wiki/Special:RecentChangesLinked/Miglustat","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Miglustat&oldid=544881193","/w/index.php?title=Miglustat&action=info","//www.wikidata.org/wiki/Q425911","/w/index.php?title=Special:Cite&page=Miglustat&id=544881193","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Miglustat","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Miglustat&oldid=544881193&writer=rl","/w/index.php?title=Miglustat&printable=yes","//de.wikipedia.org/wiki/Miglustat","//pl.wikipedia.org/wiki/Miglustat","#","//www.wikidata.org/wiki/Q425911#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Miglustat","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196758.pdf","http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000435/WC500046721.pdf","http://onlinelibrary.wiley.com/doi/10.1002/9780470742761.ch8/pdf"],"categories":["Transferase inhibitors","Orphan drugs","Piperidines"],"headings":["Biosynthesis of  Miglustat","See also","References"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Miglustat_2.svg/185px-Miglustat_2.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Miglustat_synthesis.svg/1000px-Miglustat_synthesis.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Kidney","Actelion","Gaucher_disease","Glucosylceramide_synthase","Enzyme","Glycosphingolipid","Autosomal_recessive","Glucocerebrosidase","Acid_β-glucosidase","Glucosylceramide","Glucocerebroside","Substrate_reduction_therapy","Tay-sachs_disease","Cystic_fibrosis","Amine_alkylation","Miglitol","Isofagomine_tartrate"]}